Acorda Therapeutics, Inc. Soared
Thu, Dec 26, 2019 at 05:30 PM
Acorda Therapeutics, Inc. (ACOR:NASDAQ) rocketted at $2.75, a gain of 43.2%. The stock appeared on our News Catalysts scanner on Wed 04 Dec 19 at 12:49 PM in the 'EARNINGS' category. From Wed 04 Dec 19, the stock recorded 57.14% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Acorda Therapeutics, Inc. (ACOR:NASDAQ)
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
Top 10 Gainers:
- China Rapid Finance Limited (XRF:NYSE), 113.11%
- Mereo BioPharma Group plc (MREO:NASDAQ), 97.25%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 54.1%
- Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ), 50%
- Phathom Pharmaceuticals, Inc. (PHAT:NASDAQ), 47.21%
- Verona Pharma plc (VRNA:NASDAQ), 44.93%
- Liquidia Technologies, Inc. (LQDA:NASDAQ), 43.47%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 43.23%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 37.49%
- KemPharm, Inc. (KMPH:NASDAQ), 34.79%